Benchling has seen its business grow at a healthy lick since it launched in 2012 with a mission to improve the efficiency of the biopharma R&D process, but it looks li
Life sciences venture capital company Sofinnova has launched a new strategy in digital medicine, accompanied by a series of investments in start-ups operating within the c
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.